TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36162897

Group type: EXPERIMENTAL
Intervention: Silver Diamine Fluoride (SDF) application before ART restorations
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo (tonic water) application before ART restorations
Number of subjects: 194
Study: 35902652

Group type: EXPERIMENTAL
Intervention: Inosine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 120
Study: 34158069

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (IH) for 6 hours after a meal
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normoxia for 6 hours after a meal
Number of subjects: 15
Study: 35000803

Group type: EXPERIMENTAL
Intervention: Cost-benefit group
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Risk-sharing group
Number of subjects: 269

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 269
Study: 33272281

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment in pregnancy (IPTp) with dihydroartemisinin–piperaquine (DP)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Active PM
Number of subjects: 656

Group type: COMPARATOR
Intervention: Severe past PM
Number of subjects: 656

Group type: COMPARATOR
Intervention: Mild-moderate past PM
Number of subjects: 656

Group type: COMPARATOR
Intervention: No PM
Number of subjects: 656
Study: 34982628

Group type: EXPERIMENTAL
Intervention: Personalized telephone calls from service center representatives
Number of subjects: 79522
Study: 34275096

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (20 mg daily for 5 days, followed by 10 mg daily for 5 days)
Number of subjects: 98

Group type: COMPARATOR
Intervention: CVD
Number of subjects: 98
Study: 33129261

Group type: EXPERIMENTAL
Intervention: PROfit basic group (functional strength, balance, flexibility, and walking exercises at the same location)
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: PROfit plus group (similar exercises as PROfit basic but changing locations)
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: PROfit orientation group (navigation tasks in addition to relocation during the intervention)
Number of subjects: 513

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 513
Study: 33818302

Group type: EXPERIMENTAL
Intervention: CBT‐based Complicated Grief Treatment (CGT)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Interpersonal Therapy (IPT)
Number of subjects: 131
Study: 34819047

Group type: EXPERIMENTAL
Intervention: Violence prevention only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Violence prevention and education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Violence prevention, education and health
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Violence prevention, education, health and wealth creation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education conditional cash transfer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wealth intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health intervention
Number of subjects: 0
Study: 35357459

Group type: EXPERIMENTAL
Intervention: ePRO follow-up model
Number of subjects: 278

Group type: COMPARATOR
Intervention: Traditional follow-up methods
Number of subjects: 278
Study: 34393122

Group type: EXPERIMENTAL
Intervention: GC Fuji IX
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (nano-hybrid composite)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Cention-N
Number of subjects: 160

Group type: COMPARATOR
Intervention: Etch-and-rinse adhesive (nano-hybrid composite)
Number of subjects: 160
Study: 36332541

Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam (IM)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Intranasal midazolam (IN)
Number of subjects: 130
Study: 32483928

Group type: EXPERIMENTAL
Intervention: Heated Humidified High Flow Nasal Cannula (HHHFNC)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Nasal Continuous Positive Airway Pressure (NCPAP)
Number of subjects: 64

Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: HHHFNC
Number of subjects: 64
Study: 33333521

Group type: EXPERIMENTAL
Intervention: High-Intensity Group (HIG) - 40% of maximum inspiratory pressure (MIP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low-Intensity Group (LIG) - 20% of maximum inspiratory pressure (MIP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Comparison between HIG and LIG
Number of subjects: 26
Study: 32560516

Group type: EXPERIMENTAL
Intervention: 3 g/day CLA
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 35114581

Group type: EXPERIMENTAL
Intervention: ACLR patients
Number of subjects: 23

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 23
Study: 32799393

Group type: EXPERIMENTAL
Intervention: Dichotomous key for springs ecosystem classification
Number of subjects: 244
Study: 36252412

Group type: EXPERIMENTAL
Intervention: ON-SXB 6 g
Number of subjects: 28

Group type: COMPARATOR
Intervention: Twice-nightly SXB (two 3-g doses)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: ON-SXB and Twice-nightly SXB
Number of subjects: 28
Study: 36266118

Group type: EXPERIMENTAL
Intervention: LSD (200 μg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 32854563

Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol‐containing caps
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard catheter caps
Number of subjects: 95
Study: 32147436

Group type: COMPARATOR
Intervention: Cx32 deficiency (Cx32 knockout mice)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cx32 small interfering RNA and p53 inhibitor (pifithrin-α, tenovin-1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study: 36451052

Group type: EXPERIMENTAL
Intervention: HDS with HFNC platform
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDS with HFNC platform (randomized breathing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDS with OI platform (best-case mouthpiece)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDS with OI platform (normal vs. deep randomized oral inhalation)
Number of subjects: 0
Study: 34046761

Group type: EXPERIMENTAL
Intervention: HIV care for partners living with HIV
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: PrEP care for HIV-negative partners
Number of subjects: 155

Group type: COMPARATOR
Intervention: Racial comparison of viral suppression
Number of subjects: 155
Study: 33098470

Group type: EXPERIMENTAL
Intervention: Edoxaban (60 mg/30 mg once daily) plus a P2Y12 inhibitor for 12 months
Number of subjects: 1506

Group type: COMPARATOR
Intervention: Vitamin K antagonist (VKA) plus a P2Y12 inhibitor and aspirin (100 mg OD, for 1–12 months)
Number of subjects: 1506

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 1506
Study: 35997037

Group type: EXPERIMENTAL
Intervention: Traction ESD (T-ESD)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Conventional ESD (C-ESD)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Traction ESD (T-ESD) for lesions ≥30 mm
Number of subjects: 251

Group type: COMPARATOR
Intervention: Conventional ESD (C-ESD) for lesions ≥30 mm
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Traction ESD (T-ESD) for non-expert operators
Number of subjects: 251

Group type: COMPARATOR
Intervention: Conventional ESD (C-ESD) for non-expert operators
Number of subjects: 251
Study: 34386935

Group type: EXPERIMENTAL
Intervention: Oral pioglitazone 30 mg/day (Arm A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (Arm B)
Number of subjects: 90
Study: 34799219

Group type: EXPERIMENTAL
Intervention: Ursolic acid (UA) 400 mg/day
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo 400 mg/day
Number of subjects: 27
Study: 34155173

Group type: EXPERIMENTAL
Intervention: PhD-prepared nurse educators
Number of subjects: 160

Group type: COMPARATOR
Intervention: DNP-prepared nurse educators
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Overall skill acquisition scores
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Use assessment and evaluation domain
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Engage in scholarship domain
Number of subjects: 160
Study: 32527322

Group type: EXPERIMENTAL
Intervention: Enhanced care planning with clinical-community linkage support
Number of subjects: 600

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600
Study: 34797378

Group type: EXPERIMENTAL
Intervention: Modified vacuum‐formed retainers (mVFRs)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Hawley retainers (HRs)
Number of subjects: 35
Study: 33561274

Group type: EXPERIMENTAL
Intervention: KEβHB-supplemented drink
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 34551902

Group type: EXPERIMENTAL
Intervention: Arthroscopic Bankart
Number of subjects: 122

Group type: COMPARATOR
Intervention: Open Latarjet
Number of subjects: 122
Study: 35811545

Group type: EXPERIMENTAL
Intervention: Iron supplementation (66 mg elemental iron daily as ferrous fumarate)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 119
Study: 34328479

Group type: EXPERIMENTAL
Intervention: NBS (xenograft enriched with polymer and gelatin)
Number of subjects: 20

Group type: COMPARATOR
Intervention: DBBM (deproteinized bovine bone mineral)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of NBS vs DBBM
Number of subjects: 20
Study: 32410495

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Relaxation-skills-only intervention
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Nurse self-efficacy
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intervention adherence
Number of subjects: 54
Study: 33337677

Group type: EXPERIMENTAL
Intervention: Matrix Rhythm Therapy (MRT) in addition to a combined physiotherapy program (hot pack, transcutaneous electrical nerve stimulation, therapeutic ultrasound, home exercise and patient education program)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Combined physiotherapy program (hot pack, transcutaneous electrical nerve stimulation, therapeutic ultrasound, home exercise and patient education program)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Comparison of delta values between groups
Number of subjects: 32
Study: 32183835

Group type: EXPERIMENTAL
Intervention: Multidisciplinary residential nutritional rehabilitation programme
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard care (wait-list control group)
Number of subjects: 72
Study: 35010717

Group type: EXPERIMENTAL
Intervention: Self-myofascial release technique (foam rolling)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 32484068

Group type: EXPERIMENTAL
Intervention: Neurocognitive Temporal Training (NTT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (no NTT training)
Number of subjects: 41
Study: 36321799

Group type: EXPERIMENTAL
Intervention: aboBoNT‐A injections 600 U (n = 162) or 800 U (n = 161)
Number of subjects: 485

Group type: COMPARATOR
Intervention: Placebo (n = 162)
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: aboBoNT‐A injections
Number of subjects: 485

Group type: COMPARATOR
Intervention: aboBoNT‐A injections and placebo
Number of subjects: 485
Study: 33787956

Group type: EXPERIMENTAL
Intervention: Soleus H-reflex amplitude modulation in iSCI individuals
Number of subjects: 10

Group type: COMPARATOR
Intervention: Soleus H-reflex amplitude modulation in age-matched controls (CTRL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Balance control assessment using the Berg Balance Scale
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Center of pressure (CoP) displacement analysis
Number of subjects: 10
Study: 35272494

Group type: EXPERIMENTAL
Intervention: Divalproex Sodium (VPA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 34033974

Group type: EXPERIMENTAL
Intervention: Apatinib (500 mg/d) + Gefitinib (250 mg/d)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo + Gefitinib (250 mg/d)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Apatinib + Gefitinib
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo + Gefitinib
Number of subjects: 313
Study: 32441760

Group type: EXPERIMENTAL
Intervention: HOLA intervention
Number of subjects: 166

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 166
Study: 34048943

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Nurse care management focused on analgesic treatment and optimization (MED)
Number of subjects: 261
Study: 32143611

Group type: EXPERIMENTAL
Intervention: Video case modality
Number of subjects: 45

Group type: COMPARATOR
Intervention: Paper case modality
Number of subjects: 45
Study: 616783058

Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue Tongmai decoction
Number of subjects: 95
Study: 33210299

Group type: EXPERIMENTAL
Intervention: High-dose oral thiamine (600-1800 mg/d) for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral placebo for 4 weeks
Number of subjects: 40
Study: 32772019

Group type: EXPERIMENTAL
Intervention: mHealth with interactivity (mHealth application + nurse case management supported by a social service team)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: mHealth (mHealth application only)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 282
Study: 35485626

Group type: EXPERIMENTAL
Intervention: Multimedia training programme for pain management (communication skills, assertiveness, stress management, lifestyle enhancement skills, physical activity)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine training (physician's visits, medication prescriptions, recommendations from healthcare providers)
Number of subjects: 0
Study: 33091618

Group type: EXPERIMENTAL
Intervention: 5.25 % NaOCl + 17 % EDTA
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chlorhexidine (CHX)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3.8 % Silver diamine fluoride (SDF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 40
Study: 36384935

Group type: EXPERIMENTAL
Intervention: Preoperative bathing using plain soap
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control group (no preoperative bathing)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Preoperative bathing using plain soap among participants not given preoperative antibiotics
Number of subjects: 252
Study: 33709251

Group type: EXPERIMENTAL
Intervention: Microabrasion with 35% phosphoric acid and pumice
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Microabrasion with 6.6% hydrochloric acid and silica
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 16% carbamide peroxide
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 35% H2O2
Number of subjects: 15
Study: 36481801

Group type: EXPERIMENTAL
Intervention: Deceptive placebo (DP)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP)
Number of subjects: 109

Group type: COMPARATOR
Intervention: No treatment (NT)
Number of subjects: 109
Study: 34609495

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine (maximum total daily dose of 48 mg/d)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine
Number of subjects: 119
Study: 32572777

Group type: EXPERIMENTAL
Intervention: Salvianolate
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control
Number of subjects: 149
Study: 35314069

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 35331945

Group type: EXPERIMENTAL
Intervention: Patient navigation program - Pathways to Genetic Counseling
Number of subjects: 161

Group type: COMPARATOR
Intervention: Care as usual (no contact)
Number of subjects: 161
Study: 32899030

Group type: EXPERIMENTAL
Intervention: Thread embedding acupuncture (TEA), 6 treatments over 6 weeks (1 time/week) on 14 defined knee areas.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acupuncture treatment, 12 treatments over 6 weeks (2 times/week) on 9 defined acupuncture points.
Number of subjects: 40
Study: 35472333

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl 100 mcg
Number of subjects: 107

Group type: COMPARATOR
Intervention: Intranasal placebo
Number of subjects: 107
Study: 33932433

Group type: EXPERIMENTAL
Intervention: Single flagellar motor driving cell-body rotation; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flagellar bundles on glass surfaces; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 35346849

Group type: EXPERIMENTAL
Intervention: 2 g of intravenous tranexamic acid
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 33027073

Group type: EXPERIMENTAL
Intervention: EWSR1 rearrangement detected by FISH
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: EWSR1 amplification
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Next-generation sequencing (NGS)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: PLAG1 rearrangement by FISH
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: PLAG1 fusions found in NGS
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Overall PLAG1 gene rearrangements
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: EWSR1-ATF1 fusion
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: ATF1 rearrangement by FISH
Number of subjects: 94
Study: 35086119

Group type: EXPERIMENTAL
Intervention: Binocular treatment with Dig Rush game (1 h/d, 5 d/wk for 8 weeks)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Continued spectacle correction alone
Number of subjects: 182
Study: 33147705

Group type: EXPERIMENTAL
Intervention: n-3 long-chain polyunsaturated fatty acids (n-3 PUFA) supplementation for six months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo supplementation for six months
Number of subjects: 24
Study: 34555964

Group type: EXPERIMENTAL
Intervention: Dynamic Neuromuscular Stabilization (DNS) training
Number of subjects: 40

Group type: COMPARATOR
Intervention: General Exercise (GE)
Number of subjects: 40
Study: 32387716

Group type: EXPERIMENTAL
Intervention: Fluid resuscitation protocols for children in DKA
Number of subjects: 1258
Study: 34224363

Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy after first-line chemotherapy (FL-M)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy after platinum-sensitive recurrence (PSR-M)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Olaparib active treatment (AT)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Olaparib (AT)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Olaparib (PSR-M)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 251
Study: 33043821

Group type: EXPERIMENTAL
Intervention: Recombinant zoster vaccine (RZV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zoster vaccine live (ZVL)
Number of subjects: 0
Study: 35771512

Group type: COMPARATOR
Intervention: 60-min PE sessions
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 90-min PE sessions
Number of subjects: 160
Study: 32921199

Group type: EXPERIMENTAL
Intervention: Teach-back training method (TBTM) of respiratory exercise including diaphragmatic breathing (DB), pursed-lip breathing (PLB), and effective coughing (EC) plus routine approach
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Teach-back training method (TBTM) of respiratory exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (routine approach)
Number of subjects: 80
Study: 34619054

Group type: EXPERIMENTAL
Intervention: Pediatric Weight Management Intervention (PWMI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased scores for exercising regularly
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased scores for keeping healthy food at home
Number of subjects: 0
Study: 33543216

Group type: EXPERIMENTAL
Intervention: 1% lidocaine with 1∶100 000 EPI
Number of subjects: 21

Group type: COMPARATOR
Intervention: 2% lidocaine with 1∶100 000 EPI
Number of subjects: 21
Study: 36049498

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 154664

Group type: EXPERIMENTAL
Intervention: More intensive statin regimens (40-80 mg atorvastatin or 20-40 mg rosuvastatin once per day)
Number of subjects: 154664

Group type: EXPERIMENTAL
Intervention: More intensive statin regimens
Number of subjects: 154664

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154664
Study: 33694294

Group type: EXPERIMENTAL
Intervention: Resolute Onyx stent
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Orsiro stent
Number of subjects: 1275
Study: 32377159

Group type: EXPERIMENTAL
Intervention: Probiotic oral suspension group (POSG)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Probiotic oral suspension group (POSG) in IL-1β carriers
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo control group (PCG)
Number of subjects: 150
Study: 34274514

Group type: EXPERIMENTAL
Intervention: Obeticholic Acid 25 mg
Number of subjects: 1218

Group type: EXPERIMENTAL
Intervention: Obeticholic Acid 10 mg
Number of subjects: 1218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1218
Study: 34172544

Group type: EXPERIMENTAL
Intervention: High-intensity strength training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Care-as-Usual
Number of subjects: 60
Study: 33085857

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study: 34542952

Group type: EXPERIMENTAL
Intervention: Robuvit® (300 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard management (SM)
Number of subjects: 40
Study: 33279940

Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic stem cell transplantation (HCT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Chemotherapy consolidation
Number of subjects: 124
Study: 35079844

Group type: EXPERIMENTAL
Intervention: Severely fatty-infiltrated rotator cuff muscles
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Distinct tendon retraction
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Obvious muscle atrophy
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Irreparable massive RCT (MRCT)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Δshear modulus of the ISP
Number of subjects: 133